Aspire Biopharma Inc.
Nanoformulated oral drug-delivery platform enabling instant absorption in the mouth to rapidly target pain and inflammation while bypassing the gastrointestinal tract.
Applies to approved drugs and supplements (analgesics, erectile dysfunction, traumatic brain injury therapies) for high-dose, fast-onset delivery aimed at addressing the opioid crisis.
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...
Insights
Loading Insights...
Loading Insight content to display...
Loading Insights...
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...
Funding
Workforce
Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A